[1]张 伟.动态血压监测不同剂型硝苯地平在原发性高血压患者中的治疗效果[J].医学信息,2022,35(10):152-154.[doi:10.3969/j.issn.1006-1959.2022.10.038]
 ZHANG Wei.Effect of Different Dosage Forms of Nifedipine on Ambulatory Blood Pressure Monitoring in Patients with Essential Hypertension[J].Medical Information,2022,35(10):152-154.[doi:10.3969/j.issn.1006-1959.2022.10.038]
点击复制

动态血压监测不同剂型硝苯地平在原发性高血压患者中的治疗效果()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年10期
页码:
152-154
栏目:
论著
出版日期:
2022-05-15

文章信息/Info

Title:
Effect of Different Dosage Forms of Nifedipine on Ambulatory Blood Pressure Monitoring in Patients with Essential Hypertension
文章编号:
1006-1959(2022)10-0152-03
作者:
张 伟
(天津市宁河区宁河医院全科,天津 301500)
Author(s):
ZHANG Wei
(Department of General Practice,Ninghe Hospital of Ninghe District,Tianjin 301500,China)
关键词:
原发性高血压硝苯地平动态血压监测仪
Keywords:
Essential hypertensionNifedipineAmbulatory blood pressure monitoring
分类号:
R544.1
DOI:
10.3969/j.issn.1006-1959.2022.10.038
文献标志码:
A
摘要:
目的 观察动态血压监测仪监测不同剂型硝苯地平在原发性高血压患者中的实施效果。方法 选取2018年8月-2020年8月我院收治的80例原发性高血压患者为研究对象,采用随机数字表法为对照组和观察组,各40例。对照组给予硝苯地平缓释片治疗,观察组给予硝苯地平控释片治疗,比较两组治疗前后平均血压水平、24 h内平均血压水平及不良反应发生情况。结果 两组舒张压、收缩压均低于治疗前,且观察组低于对照组,差异有统计学意义(P<0.05);两组24 h平均舒张压、收缩压均低于治疗前,且观察组低于对照组,差异有统计学意义(P<0.05);两组血尿酸水平均低于治疗前,且观察组低于对照组,差异有统计学意义(P<0.05);观察组不良反应发生率为5.00%,与对照组7.50%比较,差异无统计学意义(P>0.05)。结论 硝苯地平缓释片与硝苯地平控释片治疗原发性高血压均具有一定的降压作用,且临床应用安全性无明显差异,但硝苯地平控释片降压效果更优,且稳定。
Abstract:
Objective To observe the effect of different dosage forms of nifedipine in patients with essential hypertension monitored by ambulatory blood pressure monitor.Methods A total of 80 patients with essential hypertension admitted to our hospital from August 2018 to August 2020 were selected as the research objects, which were divided into the control group and observation group by random number table method, with 40 cases in each group. The control group was treated with nifedipine sustained-release tablets, and the observation group was treated with nifedipine controlled-release tablets. The average blood pressure level before and after treatment, the average blood pressure level within 24 h and the occurrence of adverse reactions were compared between the two groups.Results The diastolic blood pressure and systolic blood pressure of the two groups were lower than those before treatment, and those in the observation group was lower than the control group, the difference was statistically significant (P<0.05). The 24 h average diastolic blood pressure and systolic blood pressure of the two groups were lower than those before treatment, and those in the observation group was lower than the control group, the difference was statistically significant (P<0.05). The levels of serum uric acid in the two groups were lower than those before treatment, and that in the observation group was lower than the control group, the difference was statistically significant (P<0.05). The incidence of adverse reactions in the observation group was 5.00%, which was compared 7.50% in the control group, the difference was not statistically significant (P>0.05).Conclusion Nifedipine sustained release tablets and nifedipine controlled release tablets have certain antihypertensive effect in the treatment of essential hypertension, and there is no significant difference in clinical application safety, but nifedipine controlled release tablets have better antihypertensive effect and stability.

参考文献/References:

[1]王爱荷,刘书贤,杜艳青,等.老年高血压患者24小时动态血压监测参数及节律与早期肾损害的关系[J].中国医师进修杂志,2017,40(2):153-156,157.[2]杨旦红,吴菁,葛莹,等.高血压患者24h动态血压、随访血压与诊室血压测量结果比较[J].中国全科医学,2019,3(21):278-280.[3]李瑶,姚思宇,石亚君,等.高血压合并冠心病患者血压负荷与冠脉病变严重程度的关系研究[J].中国分子心脏病学杂志,2017,17(4):2144-2146.[4]应佐华,杨良瑞,高琴.硝苯地平缓释片与控释片治疗60岁以上原发性高血压患者疗效比较[J].实用临床医药杂志,2018,22(17):99-101.[5]李茜娴.硝苯地平缓释片与控释片治疗妊娠期高血压疗效对比探讨[J].现代诊断与治疗,2019,30(10):1625-1627.[6]丁燕.硝苯地平缓释片与硝苯地平控释片治疗高血压的疗效比较[J].中国药物经济学,2014(8):48-49.[7]王磊,魏新伟,于芳. 不同降压药物联合治疗对老年高血压患者血压变异性的影响[J]. 天津医药,2016,44(1):105-109.[8]魏强.高血压治疗中采用不同剂型硝苯地平的效果对比[J].临床检验杂志,2017,6(2):336-337.[9]虞春宜.偶测血压与24h动态血压监测对妊娠期高血压疾病诊断价值比较[J].蚌埠医学院学报,2017,15(1):68-70.[10]吕红华.硝苯地平控释片与硝苯地平缓释片治疗高血压效果观察[J].临床医学,2019,39(3):118-120.[11]郑晓玲,翟炜.硝苯地平缓释片与硝苯地平控释片治疗原发性高血压的疗效比较[J].临床医学,2020,40(11):97-98.[12]吴盛忠,刘长鑫,赵明星,等.动态心电图和动态血压同步监测在原发性高血压患者中的应用[J].基层医学论坛,2017,21(19):2590-2591.[13]李建敏,李晨,寿松涛.24h动态血压监测在原发性高血压患者心血管危险分层评估中的价值[J].山东医药,2017,17(24):68-70.[14]陈河清,王振清.原发性高血压患者血脂水平与血压变异性的相关分析[J].中国处方药,2018,16(5):121-122.[15]应佐华,杨良瑞,高琴.硝苯地平缓释片与控释片治疗60岁以上原发性高血压患者疗效比较[J].实用临床医药杂志,2018,9(8):75-77.[16]张波,纪大鹏.24h动态血压监测对原发性高血压患者心脑血管风险评估的价值[J].现代仪器与医疗,2018,24(2):45-46.[17]杨健.硝苯地平控释片对老年原发性高血压患者临床疗效及心率的影响[J].中国处方药,2019,17(5):69-70.[18]崔锦娜,姚远.24h动态血压监测在老年高血压患者中的应用[J].心血管康复医学杂志,2018,28(2):90-92.[19]陈登.动态血压监测对高血压诊治的临床价值分析[J].中西医结合心血管病电子杂志,2017,5(35):46.[20]潘远安,刘江红,张志超,等.硝苯地平缓释片与硝苯地平控释片治疗高血压合并糖尿病的疗效比较[J]现代诊断与治疗,2017,28(7):1225-1227.

相似文献/References:

[1]陈 萍,陈 磊.硝苯地平联合硫酸镁治疗重度妊娠高血压的临床效果分析[J].医学信息,2018,31(04):109.[doi:10.3969/j.issn.1006-1959.2018.04.037]
 CHEN Ping,CHEN Lei.Clinical Analysis of Nifedipine Combined with Magnesium Sulfate in Treating Severe Pregnancy Induced Hypertension[J].Medical Information,2018,31(10):109.[doi:10.3969/j.issn.1006-1959.2018.04.037]
[2]段淑婷,王义围,王兆鹏.高血压病合并糖调节受损患者血压变异性的相关研究[J].医学信息,2018,31(05):11.[doi:10.3969/j.issn.1006-1959.2018.05.004]
 DUAN Shu-ting,WANG Yi-wei,WANG Zhao-peng.Study on Blood Pressure Variability in Patients with Hypertension Complicated with Impaired Glucose Regulation[J].Medical Information,2018,31(10):11.[doi:10.3969/j.issn.1006-1959.2018.05.004]
[3]孙洪艳.硝苯地平联合厄贝沙坦治疗糖尿病合并高血压的疗效观察[J].医学信息,2018,31(10):131.[doi:10.3969/j.issn.1006-1959.2018.10.043]
 SUN Hong-yan.Efficacy of Nifedipine Combined with Irbesartan in the Treatment of Diabetes Complicated with Hypertension[J].Medical Information,2018,31(10):131.[doi:10.3969/j.issn.1006-1959.2018.10.043]
[4]熊依良.奥美沙坦酯氢氯噻嗪片治疗轻中度原发性高血压的疗效及安全性分析[J].医学信息,2018,31(19):142.[doi:10.3969/j.issn.1006-1959.2018.19.043]
 XIONG Yi-liang.Efficacy and Safety of Olmesartan Medoxomil and Hydrochlorothiazide Tablets in the Treatment of Mild to Moderate Essential Hypertension[J].Medical Information,2018,31(10):142.[doi:10.3969/j.issn.1006-1959.2018.19.043]
[5]李信明,刘春梅,任正强,等.供需平衡视角下原发性高血压的病机与防治[J].医学信息,2018,31(19):182.[doi:10.3969/j.issn.1006-1959.2018.19.058]
 LI Xin-Ming,LIU Chun-Mei,REN Zheng-Qiang,et al.Pathogenesis and Prevention of Essential Hypertension from the Perspective of Supply and Demand Balance[J].Medical Information,2018,31(10):182.[doi:10.3969/j.issn.1006-1959.2018.19.058]
[6]穆大明.厄贝沙坦氢氯噻嗪与福辛普利治疗原发性高血压的疗效观察[J].医学信息,2019,32(03):151.[doi:10.3969/j.issn.1006-1959.2019.03.049]
 MU Da-ming.Efficacy of Irbesartan Hydrochlorothiazide and Fosinopril in the Treatment of Essential Hypertension[J].Medical Information,2019,32(10):151.[doi:10.3969/j.issn.1006-1959.2019.03.049]
[7]潘建鑫.高血压患者血小板/淋巴细胞比值与颈动脉粥样硬化的相关性分析[J].医学信息,2020,33(05):77.[doi:10.3969/j.issn.1006-1959.2020.05.023]
 Pan Jianxin.Correlation analysis of platelet/lymphocyte ratio and carotid atherosclerosisin patients with primary hypertension[J].Medical Information,2020,33(10):77.[doi:10.3969/j.issn.1006-1959.2020.05.023]
[8]李文超.硝苯地平联合阿司匹林对妊娠期高血压患者母婴结局的影响[J].医学信息,2020,33(05):151.[doi:10.3969/j.issn.1006-1959.2020.05.049]
 LI Wen-chao.Effects of Nifedipine Combined with Aspirin on Maternal and Infant Outcomes in Patients with Gestational Hypertension[J].Medical Information,2020,33(10):151.[doi:10.3969/j.issn.1006-1959.2020.05.049]
[9]谢祥红.AngⅡ、ET-1对高血压患者病情发生发展的影响[J].医学信息,2020,33(16):75.[doi:10.3969/j.issn.1006-1959.2020.16.023]
 XIE Xiang-hong.Effects of AngⅡ and ET-1 on the Occurrence and Development of Hypertension Patients[J].Medical Information,2020,33(10):75.[doi:10.3969/j.issn.1006-1959.2020.16.023]
[10]刘 柳,吕风华.原发性高血压患者脉压与左心室肥厚及射血分数保留的心衰的相关性[J].医学信息,2021,34(01):112.[doi:10.3969/j.issn.1006-1959.2021.01.029]
 LIU Liu,LYU Feng-hua.Correlation of Pulse Pressure with Left Ventricular Hypertrophy and Heart Failure with Preserved Ejection Fraction in Patients with Essential Hypertension[J].Medical Information,2021,34(10):112.[doi:10.3969/j.issn.1006-1959.2021.01.029]

更新日期/Last Update: 1900-01-01